• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧细胞增敏剂在多细胞球体中的细胞毒性。

Cytotoxicity of hypoxic cell sensitizers in multicell spheroids.

作者信息

Sutherland R M, Bareham B J, Reich K A

出版信息

Cancer Clin Trials. 1980 Spring;3(1):73-83.

PMID:7389039
Abstract

Multicell tumor spheroids of EMT6/Ro cells were used to evaluate the cytotoxicity of several hypoxic cell sensitizers. The number of clonogenic cells per spheroid was determined after different exposure periods and concentrations of misonidazole, Ro-05-9963, and SR 2508 which have similar electron affinities. The kinetics of cytotoxicity were similar for each drug and the clonogenic fraction was reduced by about 0.5 to a plateau level after 24 hours at 3.0 mM for spheroids grown in 20% O2. Extended exposure periods caused additional cytotoxicity for both Ro-05-9963 and SR 2508. Lower concentrations (0.5 mM) of these sensitizers were not cytotoxic even in spheroids grown in low concentrations of oxygen (2.5% O2) to increase the hypoxic fraction. However, at cytotoxic concentrations (3.0 mM) spheroids grown in this low oxygen concentration exhibited almost twice as much cytotoxicity. No cytotoxicity was produced at 3.0 mM misonidazole in small spheroids without necrotic centers and hypoxic cells. In addition to being cytotoxic, continuous exposure of spheroids to high concentrations (3.0 mM) of misonidazole were cytostatic. The spheroid experiments were predictive of the relative effectiveness of the different sensitizers for EMT6/Ro tumors in vivo but the rate and extent of cytotoxicity was greater in tumors especially at low concentrations. In both spheroids and tumors there was little change in growth rate after 24 hours or single intraperitoneal exposures respectively, even with concentrations which reduced the clonogenic fraction by 0.9. This was related to a rapid repopulation of cells and increase in growth fraction after misonidazole cytotoxicity. Addition of adriamycin immediately after misonidazole cytotoxicity resulted in an apparent supra-additive overall response. The significance of these results for interpretation of tumor properties and responses in vivo and for tumor therapy were discussed.

摘要

使用EMT6/Ro细胞的多细胞肿瘤球体来评估几种乏氧细胞增敏剂的细胞毒性。在不同暴露时间以及米索硝唑、Ro-05-9963和SR 2508(它们具有相似的电子亲和力)的不同浓度作用后,测定每个球体中克隆形成细胞的数量。每种药物的细胞毒性动力学相似,对于在20%氧气环境中生长的球体,在3.0 mM浓度下作用24小时后,克隆形成分数降低约0.5至平台水平。延长暴露时间对Ro-05-9963和SR 2508均产生额外的细胞毒性。这些增敏剂的较低浓度(0.5 mM)即使在低氧浓度(2.5%氧气)环境中生长以增加乏氧分数的球体中也无细胞毒性。然而,在细胞毒性浓度(3.0 mM)下,在此低氧浓度环境中生长的球体表现出几乎两倍的细胞毒性。在无坏死中心和乏氧细胞的小球体中,3.0 mM米索硝唑未产生细胞毒性。除具有细胞毒性外,球体持续暴露于高浓度(3.0 mM)米索硝唑还具有细胞生长抑制作用。球体实验可预测不同增敏剂对体内EMT6/Ro肿瘤的相对有效性,但细胞毒性的速率和程度在肿瘤中更大,尤其是在低浓度时。在球体和肿瘤中,分别在24小时或单次腹腔注射后,即使使用使克隆形成分数降低0.9的浓度,生长速率变化也很小。这与米索硝唑细胞毒性后细胞的快速再增殖和生长分数增加有关。在米索硝唑细胞毒性后立即添加阿霉素导致明显的超相加总体反应。讨论了这些结果对于体内肿瘤特性和反应的解释以及肿瘤治疗的意义。

相似文献

1
Cytotoxicity of hypoxic cell sensitizers in multicell spheroids.缺氧细胞增敏剂在多细胞球体中的细胞毒性。
Cancer Clin Trials. 1980 Spring;3(1):73-83.
2
Cytotoxicity of adriamycin in MGH-U1 cells grown as monolayer cultures, spheroids, and xenografts in immune-deprived mice.阿霉素对在免疫缺陷小鼠体内以单层培养物、球体和异种移植形式生长的MGH-U1细胞的细胞毒性。
Cancer Res. 1984 Nov;44(11):5369-75.
3
An in vitro and in vivo screening system for new hypoxic cell radiosensitizers using EMT6 cells.一种使用EMT6细胞的新型乏氧细胞放射增敏剂的体外和体内筛选系统。
Jpn J Cancer Res. 1986 Oct;77(10):1027-33.
4
The response of EMT6 tumor spheroids to combined treatment with misonidazole and either nitrogen mustard, adriamycin, or BCNU.EMT6肿瘤球体对米索硝唑与氮芥、阿霉素或卡氮芥联合治疗的反应。
Cancer Clin Trials. 1980 Fall;3(3):253-6.
5
Proliferative and clonogenic heterogeneity of cells from EMT6/Ro multicellular spheroids induced by the glucose and oxygen supply.葡萄糖和氧气供应诱导的EMT6/Ro多细胞球体中细胞的增殖和克隆异质性
Cancer Res. 1986 Jul;46(7):3513-20.
6
The effects of misonidazole during continuous low dose rate irradiation.米索硝唑在连续低剂量率照射期间的作用。
Cancer Clin Trials. 1980 Fall;3(3):257-65.
7
Comparison of binding of [3H]misonidazole and [14C]misonidazole in multicell spheroids.多细胞球体中[3H]米索硝唑与[14C]米索硝唑结合的比较。
Radiat Res. 1985 Mar;101(3):473-9.
8
Further characterization of 4-bromomisonidazole as a potential detector of hypoxic cells.4-溴米索硝唑作为低氧细胞潜在检测剂的进一步特性研究。
Radiat Res. 1985 Apr;102(1):76-85.
9
Cytotoxicity of radiosensitizers in multicell spheroids: combination treatment with hyperthermia.放射增敏剂在多细胞球体中的细胞毒性:与热疗的联合治疗
Br J Cancer Suppl. 1978 Jun;3:168-72.
10
Shedding of mitotic cells from the surface of multicell spheroids during growth.生长过程中多细胞球体表面有丝分裂细胞的脱落。
J Cell Physiol. 1981 Jan;106(1):23-32. doi: 10.1002/jcp.1041060104.

引用本文的文献

1
Role of N-cadherin cis and trans interfaces in the dynamics of adherens junctions in living cells.N-钙黏蛋白顺式和反式界面在活细胞中黏着连接动态中的作用。
PLoS One. 2013 Dec 2;8(12):e81517. doi: 10.1371/journal.pone.0081517. eCollection 2013.
2
In vivo response of KHT sarcomas to combination chemotherapy with radiosensitizers and BCNU.KHT肉瘤对放疗增敏剂与卡氮芥联合化疗的体内反应。
Br J Cancer. 1981 Jan;43(1):93-9. doi: 10.1038/bjc.1981.13.
3
Interactions between misonidazole and hyperthermia in EMT6 spheroids.米索硝唑与热疗在EMT6球体中的相互作用。
Br J Cancer. 1981 Dec;44(6):810-8. doi: 10.1038/bjc.1981.279.
4
Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.小鼠肿瘤对洛莫司汀与米索硝唑及其他辐射增敏剂联合用药的反应。
Br J Cancer. 1982 Feb;45(2):272-81. doi: 10.1038/bjc.1982.43.
5
Modulation of the hypoxic toxicity and binding of misonidazole by glucose.葡萄糖对米索硝唑的低氧毒性及结合的调节作用。
Br J Cancer. 1986 Dec;54(6):911-7. doi: 10.1038/bjc.1986.261.
6
Multicellular spheroids. A review on cellular aggregates in cancer research.多细胞球体。癌症研究中细胞聚集体的综述。
J Cancer Res Clin Oncol. 1987;113(2):101-22. doi: 10.1007/BF00391431.